Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × vandetanib × Clear all

NCT00686036 2016-12-21

ZENITH

Phase 2 Terminated

17 enrolled 4 charts

Prostatic Neoplasms

NCT00498797 2016-10-07

E3-Hormone Refractory Prostrate Cancer Taxotere Combination

Phase 2 Completed

86 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms